Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Oct;16(4):514–518. doi: 10.1128/aac.16.4.514

In vitro antimicrobial inhibition patterns of nutritionally variant streptococci.

R C Cooksey, J M Swenson
PMCID: PMC352891  PMID: 518081

Abstract

Twenty-four isolates of nutritionally variant streptococci, previously categorized as species included among the viridans streptococci, were tested for susceptibility to 12 antimicrobial agents. Minimum inhibitory concentrations for these isolates and for a control group of viridans streptococci with no apparent nutritional deficiencies were determined in two microdilution systems. Pyridoxal hydrochloride, which enhances growth of the nutritional variants, was added to one of these microdilution systems but not to the other. An agar dilution method was also used to test the nutritionally variant isolates. Minimum inhibitory concentrations determined by the three methods compared favorably. Penicillin, nafcillin, methicillin, and clindamycin were less effective in vitro against the nutritional variants than were the other antibiotics tested. Streptomycin, however, was less effective against the control isolates.

Full text

PDF
514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carey R. B., Brause B. D., Roberts R. B. Antimicrobial therapy of vitamin B6-dependent streptococcal endocarditis. Ann Intern Med. 1977 Aug;87(2):150–154. doi: 10.7326/0003-4819-87-2-150. [DOI] [PubMed] [Google Scholar]
  2. Cooksey R. C., Thompson F. S., Facklam R. R. Physiological characterization of nutritionally variant streptococci. J Clin Microbiol. 1979 Sep;10(3):326–330. doi: 10.1128/jcm.10.3.326-330.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. George R. H. The isolation of symbiotic streptococci. J Med Microbiol. 1974 Feb;7(1):77–83. doi: 10.1099/00222615-7-1-77. [DOI] [PubMed] [Google Scholar]
  4. Mandell G. L., Kaye D., Levison M. E., Hook E. W. Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med. 1970 Feb;125(2):258–264. doi: 10.1001/archinte.125.2.258. [DOI] [PubMed] [Google Scholar]
  5. McCarthy L. R., Bottone E. J. Bacteremia and endocarditis caused by satelliting streptococci. Am J Clin Pathol. 1974 May;61(5):585–591. doi: 10.1093/ajcp/61.5.585. [DOI] [PubMed] [Google Scholar]
  6. Moellering R. C., Jr, Wennersten C., Weinberg A. N. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J Lab Clin Med. 1971 May;77(5):821–828. [PubMed] [Google Scholar]
  7. Phillips I., Warren C., Harrison J. M., Sharples P., Ball L. C., Parker M. T. Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin. J Med Microbiol. 1976 Nov;9(4):393–404. doi: 10.1099/00222615-9-4-393. [DOI] [PubMed] [Google Scholar]
  8. Resnick L., Cohen L. Antibiotic treatment of penicillin-sensitive streptococcal endocarditis. JAMA. 1979 Apr 27;241(17):1826–1827. [PubMed] [Google Scholar]
  9. Sande M. A., Irvin R. G. Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis. 1974 May;129(5):572–576. doi: 10.1093/infdis/129.5.572. [DOI] [PubMed] [Google Scholar]
  10. Spencer W. H., 3rd, Thornsberry C., Moody M. D., Wenger N. K. Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms. Ann Intern Med. 1970 Nov;73(5):683–687. doi: 10.7326/0003-4819-73-5-683. [DOI] [PubMed] [Google Scholar]
  11. Sprunt K., Leidy G., Redman W. Cross resistance between lincomycin and erythromycin in viridans streptococci. Pediatrics. 1970 Jul;46(1):84–88. [PubMed] [Google Scholar]
  12. Sprunt K., Redman W., Leidy G. Penicillin resistant alpha Streptococci in pharynx of patients given oral penicillin. Pediatrics. 1968 Dec;42(6):957–968. [PubMed] [Google Scholar]
  13. Sukchotiratana M., Linton A. H., Fletcher J. P. Antibiotics and the oral streptococci of man. J Appl Bacteriol. 1975 Jun;38(3):277–294. doi: 10.1111/j.1365-2672.1975.tb00531.x. [DOI] [PubMed] [Google Scholar]
  14. Tan J. S., Kaplan S., Terhune C. A., Jr, Hamburger M. Successful two-week treatment schedule for penicillin-susceptible streptococcus viridans endocarditis. Lancet. 1971 Dec 18;2(7738):1340–1343. doi: 10.1016/s0140-6736(71)92360-9. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES